BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
(+34%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
14.78%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
149
New
11
Increased
79
Reduced
34
Closed
11
Top Buys
| 1 |
Abbott
ABT
|
$14.5M |
| 2 |
Pacific Biosciences
PACB
|
$13.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 4 |
CareDx
CDNA
|
$9.72M |
| 5 |
Medtronic
MDT
|
$9.3M |
Top Sells
| 1 |
DexCom
DXCM
|
$28.5M |
| 2 |
Bausch Health
BHC
|
$3.02M |
| 3 |
Amgen
AMGN
|
$2.27M |
| 4 |
Gilead Sciences
GILD
|
$1.76M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 93.18% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0.34% |
| 4 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
51
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.85M | 0.62% |
1,339,502
+153,000
| +13% | +$1.12M |
|
|
52
CareDx
CDNA
$678M
| $9.72M | 0.62% |
+337,049
| New | +$9.72M |
|
53
Integra LifeSciences
IART
$1.18B
| $9.33M | 0.59% |
141,620
+83,459
| +143% | +$5.5M |
|
|
WCG
54
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.06M | 0.57% |
28,269
+6,219
| +28% | +$1.99M |
|
55
Globus Medical
GMED
$7.94B
| $8.59M | 0.54% |
151,251
+77,206
| +104% | +$4.38M |
|
56
Thermo Fisher Scientific
TMO
$183B
| $8.41M | 0.53% |
34,471
+5,340
| +18% | +$1.3M |
|
57
Vertex Pharmaceuticals
VRTX
$102B
| $7.81M | 0.5% |
40,494
-1,800
| -4% | -$347K |
|
|
58
Amgen
AMGN
$153B
| $7.66M | 0.49% |
36,950
-10,950
| -23% | -$2.27M |
|
59
Omnicell
OMCL
$1.51B
| $7.52M | 0.48% |
104,650
+40,705
| +64% | +$2.93M |
|
60
Molina Healthcare
MOH
$9.6B
| $7.51M | 0.48% |
50,478
-1,762
| -3% | -$262K |
|
|
HMSY
61
DELISTED
HMS Holdings Corp.
HMSY
| $7.45M | 0.47% |
227,020
+80,951
| +55% | +$2.66M |
|
|
TRHC
62
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $7.05M | 0.45% |
86,884
+19,578
| +29% | +$1.59M |
|
|
XENT
63
DELISTED
Intersect ENT, Inc
XENT
| $6.73M | 0.43% |
234,227
+146,199
| +166% | +$4.2M |
|
64
Quanterix
QTRX
$202M
| $6.71M | 0.43% |
313,230
+147,750
| +89% | +$3.16M |
|
65
iRhythm Technologies
IRTC
$5.67B
| $6.59M | 0.42% |
69,661
+23,740
| +52% | +$2.25M |
|
66
Cooper Companies
COO
$13.3B
| $6.32M | 0.4% |
91,244
+14,044
| +18% | +$973K |
|
67
Idexx Laboratories
IDXX
$50.7B
| $6.07M | 0.38% |
24,307
+17,307
| +247% | +$4.32M |
|
68
Inogen
INGN
$213M
| $5.68M | 0.36% |
23,261
+17,250
| +287% | +$4.21M |
|
|
QTNT
69
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.45M | 0.35% |
18,046
+10,051
| +126% | +$3.04M |
|
70
HCA Healthcare
HCA
$95.4B
| $5.13M | 0.33% |
36,888
+17,888
| +94% | +$2.49M |
|
71
Neurocrine Biosciences
NBIX
$13.5B
| $5.11M | 0.32% |
41,550
-2,000
| -5% | -$246K |
|
72
Qiagen
QGEN
$10.1B
| $5.08M | 0.32% |
126,548
+54,085
| +75% | +$2.17M |
|
73
Teleflex
TFX
$5.57B
| $4.73M | 0.3% |
17,792
+3,792
| +27% | +$1.01M |
|
74
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.64M | 0.29% |
47,869
-1,650
| -3% | -$160K |
|
|
NVRO
75
DELISTED
NEVRO CORP.
NVRO
| $4.58M | 0.29% |
80,415
+54,617
| +212% | +$3.11M |
|